As of August 1st 2020, Encapsulate Pharma will commence as the Distribution Partner for Merz Therapeutics in the Australian market. This will involve the Marketing, Sales and Distribution of Merz Pharmaceuticals innovative Incobotulinum Toxin Type A (Xeomin®) in all approved Therapeutic Indications. Founder and Managing Director of Encapsulate Pharma, Jay Calder, has spent the last three and a half years...
Encapsulate Pharma becomes Distribution Partner for Merz Therapeutics in the Australian Market |